98 related articles for article (PubMed ID: 19034156)
1. Expression of estrogen receptor beta in colon cancer progression.
Castiglione F; Taddei A; Rossi Degl'Innocenti D; Buccoliero AM; Bechi P; Garbini F; Chiara FG; Moncini D; Cavallina G; Marascio L; Freschi G; Gian LT
Diagn Mol Pathol; 2008 Dec; 17(4):231-6. PubMed ID: 19034156
[TBL] [Abstract][Full Text] [Related]
2. Loss of expression of oestrogen receptor beta in colon cancer and its association with Dukes' staging.
Jassam N; Bell SM; Speirs V; Quirke P
Oncol Rep; 2005 Jul; 14(1):17-21. PubMed ID: 15944762
[TBL] [Abstract][Full Text] [Related]
3. Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer.
Campbell-Thompson M; Lynch IJ; Bhardwaj B
Cancer Res; 2001 Jan; 61(2):632-40. PubMed ID: 11212261
[TBL] [Abstract][Full Text] [Related]
4. Selective loss of estrogen receptor beta in malignant human colon.
Foley EF; Jazaeri AA; Shupnik MA; Jazaeri O; Rice LW
Cancer Res; 2000 Jan; 60(2):245-8. PubMed ID: 10667568
[TBL] [Abstract][Full Text] [Related]
5. Tumor repressive functions of estrogen receptor beta in SW480 colon cancer cells.
Hartman J; Edvardsson K; Lindberg K; Zhao C; Williams C; Ström A; Gustafsson JA
Cancer Res; 2009 Aug; 69(15):6100-6. PubMed ID: 19602591
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor-beta as a potential target for colon cancer prevention: chemoprevention of azoxymethane-induced colon carcinogenesis by raloxifene in F344 rats.
Janakiram NB; Steele VE; Rao CV
Cancer Prev Res (Phila); 2009 Jan; 2(1):52-9. PubMed ID: 19139018
[TBL] [Abstract][Full Text] [Related]
7. Correlated downregulation of estrogen receptor beta and the circadian clock gene Per1 in human colorectal cancer.
Mostafaie N; Kállay E; Sauerzapf E; Bonner E; Kriwanek S; Cross HS; Huber KR; Krugluger W
Mol Carcinog; 2009 Jul; 48(7):642-7. PubMed ID: 19148895
[TBL] [Abstract][Full Text] [Related]
8. Expression of estrogen receptor β1 in colorectal cancer: correlation with clinicopathological variables.
Rath-Wolfson L; Purim O; Ram E; Morgenstern S; Koren R; Brenner B
Oncol Rep; 2012 Jun; 27(6):2017-22. PubMed ID: 22407332
[TBL] [Abstract][Full Text] [Related]
9. Oestrogen receptor-related receptor alpha (ERRalpha) and oestrogen receptors (ERalpha and ERbeta) exhibit different gene expression in human colorectal tumour progression.
Cavallini A; Notarnicola M; Giannini R; Montemurro S; Lorusso D; Visconti A; Minervini F; Caruso MG
Eur J Cancer; 2005 Jul; 41(10):1487-94. PubMed ID: 15949936
[TBL] [Abstract][Full Text] [Related]
10. Detection of mRNA levels for the estrogen alpha, estrogen beta and androgen nuclear receptor genes in archival breast cancer tissue.
Smith RA; Lea RA; Weinstein SR; Griffiths LR
Cancer Lett; 2006 Jun; 237(2):248-55. PubMed ID: 16046054
[TBL] [Abstract][Full Text] [Related]
11. Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma: correlation with prothymosin alpha and clinicopathological parameters.
Wang M; Pan JY; Song GR; Chen HB; An LJ; Qu SX
Eur J Surg Oncol; 2007 Mar; 33(2):195-201. PubMed ID: 17046193
[TBL] [Abstract][Full Text] [Related]
12. The changes of estrogen receptor-beta variants expression in breast carcinogenesis: Decrease of estrogen receptor-beta2 expression is the key event in breast cancer development.
Park BW; Kim KS; Heo MK; Yang WI; Kim SI; Kim JH; Kim GE; Lee KS
J Surg Oncol; 2006 May; 93(6):504-10. PubMed ID: 16615154
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of histamine H1 and H4 receptors suggests disturbance of local regulation in human colorectal tumours by histamine.
Boer K; Helinger E; Helinger A; Pocza P; Pos Z; Demeter P; Baranyai Z; Dede K; Darvas Z; Falus A
Eur J Cell Biol; 2008 Apr; 87(4):227-36. PubMed ID: 18258331
[TBL] [Abstract][Full Text] [Related]
14. Expression levels of estrogen receptor-alpha, estrogen receptor-beta, coactivators, and corepressors in breast cancer.
Kurebayashi J; Otsuki T; Kunisue H; Tanaka K; Yamamoto S; Sonoo H
Clin Cancer Res; 2000 Feb; 6(2):512-8. PubMed ID: 10690532
[TBL] [Abstract][Full Text] [Related]
15. The protective effect of estrogen against chemically induced murine colon carcinogenesis is associated with decreased CpG island methylation and increased mRNA and protein expression of the colonic vitamin D receptor.
Smirnoff P; Liel Y; Gnainsky J; Shany S; Schwartz B
Oncol Res; 1999; 11(6):255-64. PubMed ID: 10691027
[TBL] [Abstract][Full Text] [Related]
16. Application of cDNA microarrays to generate a molecular taxonomy capable of distinguishing between colon cancer and normal colon.
Zou TT; Selaru FM; Xu Y; Shustova V; Yin J; Mori Y; Shibata D; Sato F; Wang S; Olaru A; Deacu E; Liu TC; Abraham JM; Meltzer SJ
Oncogene; 2002 Jul; 21(31):4855-62. PubMed ID: 12101425
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor subtypes in ovarian cancer: a clinical correlation.
Chan KK; Wei N; Liu SS; Xiao-Yun L; Cheung AN; Ngan HY
Obstet Gynecol; 2008 Jan; 111(1):144-51. PubMed ID: 18165403
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of beta3-adrenergic receptor mRNA in human colon cancer: a preliminary study.
Perrone MG; Notarnicola M; Caruso MG; Tutino V; Scilimati A
Oncology; 2008; 75(3-4):224-9. PubMed ID: 18852493
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays.
Latil A; Bièche I; Vidaud D; Lidereau R; Berthon P; Cussenot O; Vidaud M
Cancer Res; 2001 Mar; 61(5):1919-26. PubMed ID: 11280747
[TBL] [Abstract][Full Text] [Related]
20. Frequent loss of estrogen and progesterone receptors in human prostatic tumors determined by quantitative real-time PCR.
Ji Q; Liu PI; Elshimali Y; Stolz A
Mol Cell Endocrinol; 2005 Jan; 229(1-2):103-10. PubMed ID: 15607534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
